Despite the fact that deregulated NLRP3 inflammasome activation potentially contributes to the pathogenesis of chronic inflammatory or metabolic disorders such as type 2 diabetes and Alzheimer’s disease3, 4, the underlying mechanism by which NLRP3 inflammasome signaling is initiated or potentiated remains still elusive. Here, NLRP3 is linked to metabolic disease.